Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $11.3M | $9.62M | $8.37M | $5.44M | $10.3M | $8.81M | $9.83M | $8.63M | $8.97M |
| Revenue growth | — | — | -14.7% | -13.0% | -35.1% | 89.5% | -14.5% | 11.6% | -12.2% | 4.0% |
| Gross profit | $6.31M | $6.97M | $4.43M | $5.72M | $3.62M | $6.31M | $4.90M | $6.79M | $6.43M | $6.41M |
| Gross margin | — | 61.8% | 46.1% | 68.3% | 66.6% | 61.3% | 55.7% | 69.1% | 74.6% | 71.4% |
| Operating income | -$6.51M | -$5.23M | -$8.00M | -$4.00M | -$7.45M | -$7.38M | -$8.83M | -$7.11M | -$6.76M | -$5.70M |
| Operating margin | — | -46.4% | -83.1% | -47.8% | -137.1% | -71.6% | -100.2% | -72.3% | -78.3% | -63.5% |
| Net income | -$5.95M | -$5.19M | -$7.43M | -$7.52M | -$7.34M | -$6.82M | -$8.71M | -$6.93M | -$4.71M | -$5.72M |
| Net margin | — | -46.0% | -77.2% | -89.8% | -134.9% | -66.2% | -98.9% | -70.5% | -54.6% | -63.8% |
| EPS (diluted) | -$0.22 | -$0.16 | -$0.21 | -$0.16 | -$0.12 | -$0.10 | — | — | -$0.06 | -$0.07 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.40M | -$1.23M | -$1.63M | -$1.78M | -$6.98M | -$4.03M | -$6.03M | -$5.33M | -$2.92M | -$2.92M |
| Capital expenditures | $15.3K | $6.01K | $7.40K | $9.92K | $21.4K | $15.2K | $8.53K | — | $10.1K | $15.1K |
| Free cash flow | -$5.41M | -$1.24M | -$1.64M | -$1.79M | -$7.01M | -$4.05M | -$6.04M | — | -$2.93M | -$2.93M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.60M | $2.64M | $743K | $1.52M | $14.2M | $14.8M | $8.72M | $2.98M | $3.26M | $1.11M |
| Total assets | $14.2M | $15.6M | $6.40M | $6.56M | $19.6M | $19.8M | $13.7M | $11.4M | $9.80M | $7.81M |
| Total liabilities | $5.65M | $8.13M | $4.87M | $4.93M | $3.46M | $3.59M | $3.70M | $3.36M | $3.96M | $4.99M |
| Shareholders' equity | $8.50M | $7.24M | $1.54M | $1.70M | $16.2M | $16.4M | $10.2M | $8.01M | $5.83M | $2.81M |
| Retained earnings | -$73.4M | -$78.6M | -$86.0M | -$93.5M | -$101M | -$108M | -$116M | -$123M | -$128M | -$134M |
| Shares (wtd avg diluted) | 27.0M | 32.7M | 35.3M | 45.7M | 63.1M | 68.8M | 70.6M | 72.8M | 79.8M | 82.1M |
Every figure is extracted from MILESTONE SCIENTIFIC INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.